Quentin M. Anstee

Has grant

Newcastle University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

SOLID: Stratification Of LIver Disease

Open Date: 2021-09-01

Close Date: 2024-09-01

Grant: Close

EU-PEARL: EU Patient-cEntric clinicAl tRial pLatform

Open Date: 2019-01-01

Close Date: 2023-01-01

Grant: Close

Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS)

Open Date: 2017-11-01

Close Date: 2024-02-01

Grant: Close

MICA: Exploring a new perspective on the mechanism of action of Glucokinase Activators in liver, a preclinical study

Open Date: 2017-01-16

Close Date: 2020-01-15

Grant: Close

Elucidating Pathways of Steatohepatitis (EPoS)

Open Date: 2015-05-01

Close Date: 2019-04-01

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Luca Miele

Catholic University of the Sacred Heart

ITALY

View details

Davide Fortin

Barcelona Institute for Global Health

SPAIN

View details

Arun Sanyal

Professor of Medicine

Virginia Commonwealth University

UNITED STATES

View details

Loranne Agius

Professor, Principal Investigator

Newcastle University

UNITED KINGDOM

View details

Olivier Govaere

Tenure Track Professor

KU Leuven

BELGIUM

View details

Philip Newsome

University of Birmingham

UNITED KINGDOM

View details

Maria Paula Macedo

Full Professor

PORTUGAL

View details

MOJGAN MASOODI

Associate Professor

Inselspital Universitätsspital Bern

SWITZERLAND

View details

helen jarvis

GP Clinical Lecturer

Newcastle University

UNITED KINGDOM

View details

Juan Pablo Arab

Western University

CANADA

View details

Stephen A. Harrison

University of Oxford

UNITED KINGDOM

View details

sven Francque

Antwerp University Hospital

BELGIUM

View details

Steven Masson

Honorary Clinical Senior Lecturer

Newcastle University

UNITED KINGDOM

View details

Nicolas Goossens

Chargé de Cours, Lecturer

University of Geneva

SWITZERLAND

View details

Luca V. C. Valenti

ITALY

View details

Simon Cockell

Senior Lecturer

Newcastle University

UNITED KINGDOM

View details

Ann Daly

Professor

Newcastle University

UNITED KINGDOM

View details

Joanne Verheij

Prof. dr.

Amsterdam UMC

NETHERLANDS

View details

Javier Crespo

Profesor Titular

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Quentin M. Anstee

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.

Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis

A roadmap for clinical trials in MASH-related compensated cirrhosis

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply

Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study

Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326.

The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326

Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study

Machine learning algorithm improves detection of NASH (NAS-based) and at-risk NASH, a development and validation study.

Machine learning algorithm improves detection of NASH (NAS-based) and at-risk NASH, a development and validation study

A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

A global action agenda for turning the tide on fatty liver disease

Collaborators (19)

Luca Miele

Davide Fortin

Arun Sanyal

Loranne Agius

Olivier Govaere

Philip Newsome

Maria Paula Macedo

MOJGAN MASOODI

helen jarvis

Juan Pablo Arab

Stephen A. Harrison

sven Francque

Steven Masson

Nicolas Goossens

Luca V. C. Valenti

Simon Cockell

Ann Daly

Joanne Verheij

Javier Crespo

Make your next move.